{"id":3883,"date":"2022-10-11T17:17:56","date_gmt":"2022-10-11T09:17:56","guid":{"rendered":"https:\/\/regask.com\/?p=3883"},"modified":"2024-11-22T05:27:00","modified_gmt":"2024-11-21T21:27:00","slug":"dezentrale-klinische-studien-cros","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/decentralized-clinical-trials-cros\/","title":{"rendered":"Dezentrale klinische Studien: Wie CROs davon profitieren k\u00f6nnen \u2026"},"content":{"rendered":"<p>Da die COVID-19-Pandemie die klinische Forschung weiterhin st\u00f6rt, besteht in der Pharma- und CRO-Industrie ein erh\u00f6hter Bedarf an der Durchf\u00fchrung dezentraler oder hybrider klinischer Studien (DCTs), um die Effizienz klinischer Studien zu verbessern.<\/p>\n<p><strong>Lesen Sie unsere Fallstudie, um zu erfahren, wie RegASK CROs dabei unterst\u00fctzt, die gesetzlichen Anforderungen f\u00fcr die Implementierung von DCTs in verschiedenen L\u00e4ndern zu erf\u00fcllen.<\/strong><\/p>\n<h2 class=\"h4\"><strong>Herausforderung<\/strong><\/h2>\n<p>Eine virtuelle Forschungsorganisation wollte regulatorische Einblicke in DCTs in 16 L\u00e4ndern\/Regionen gewinnen, um die Durchf\u00fchrung klinischer Studien besser steuern zu k\u00f6nnen. Es ist jedoch nicht einfach, sich im regulatorischen Umfeld der DCTs zurechtzufinden und die Einhaltung der Vorschriften zu gew\u00e4hrleisten. Die Vorschriften unterscheiden sich erheblich von Land zu Land und sind nicht immer vollst\u00e4ndig ausgereift. Life-Science-Unternehmen und CROs unterliegen regulatorischen \u00c4nderungen, die zu Unsicherheiten und Verz\u00f6gerungen bei der Durchf\u00fchrung klinischer Studien f\u00fchren.<\/p>\n<h2 class=\"h4\"><strong>L\u00f6sung<\/strong><\/h2>\n<p>RegASK stellte umfassende L\u00f6sungen f\u00fcr regulatorische Angelegenheiten zu DCTs bereit, darunter:<\/p>\n<ul>\n<li>Voll <strong>Reisef\u00fchrer<\/strong> Beantwortung von Fragen zu den Vorschriften f\u00fcr klinische Studien, vom Studiendesign bis hin zu einer Schritt-f\u00fcr-Schritt-Anleitung zur Registrierung einer klinischen Studie<\/li>\n<li>A <strong>Wissenskarte<\/strong> Beantwortung spezifischer regulatorischer Fragen<\/li>\n<li>Ein Fahrplan f\u00fcr den Einreichungsprozess<\/li>\n<li>Zugang zum <a href=\"https:\/\/regask.com\/de\/our-solution\/#detect\" target=\"_blank\" rel=\"noopener\">RegAlert-Plattform zur Regulierungs\u00fcberwachung<\/a> das KI nutzt, um Updates bereitzustellen f\u00fcr <strong>Reisef\u00fchrer<\/strong> Und <strong>Wissenskarte<\/strong><\/li>\n<\/ul>\n<h2 class=\"h4\"><strong>Ergebnisse<\/strong><\/h2>\n<p>Der Kunde erlangte spezifisches regulatorisches Fachwissen, das intern nicht vorhanden war, und reduzierte die \u00dcberwachungskosten (keine zus\u00e4tzlichen Mitarbeiter erforderlich). Noch wichtiger war, dass er hinsichtlich der regulatorischen \u00c4nderungen bei DCTs beruhigt war und sich auf die Skalierung seines Gesch\u00e4fts konzentrieren konnte.<\/p>","protected":false},"excerpt":{"rendered":"<p>Da die COVID-19-Pandemie die klinische Forschung weiterhin beeintr\u00e4chtigt, besteht in der pharmazeutischen Industrie und bei CROs ein erh\u00f6hter Bedarf an dezentralen oder hybriden klinischen Studien (DCTs), um die Effizienz klinischer Studien zu verbessern. Lesen Sie unsere Fallstudie, um zu erfahren, wie RegASK CROs bei der Erf\u00fcllung der regulatorischen Anforderungen f\u00fcr die Durchf\u00fchrung von DCTs in verschiedenen L\u00e4ndern unterst\u00fctzt. Herausforderung\u2026<\/p>","protected":false},"author":39,"featured_media":3954,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17,21],"tags":[],"class_list":["post-3883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-study","category-pharma-and-biotech"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Decentralized CT: CROs Benefit from RegGuides | RegASK<\/title>\n<meta name=\"description\" content=\"Learn how RegASK assists CROs in fulfilling the regulatory requirements for implementing Decentralized Clinical Trials across countries.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/dezentrale-klinische-studien-cros\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Decentralized Clinical Trials: How CROs can benefit from our RegGuides\" \/>\n<meta property=\"og:description\" content=\"Learn how RegASK assists CROs in fulfilling the regulatory requirements for implementing Decentralized Clinical Trials across countries.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/dezentrale-klinische-studien-cros\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-11T09:17:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-21T21:27:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Decentralized Clinical Trials: How CROs can benefit fro&hellip;\",\"datePublished\":\"2022-10-11T09:17:56+00:00\",\"dateModified\":\"2024-11-21T21:27:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/\"},\"wordCount\":243,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png\",\"articleSection\":[\"Case Studies\",\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/\",\"name\":\"Decentralized CT: CROs Benefit from RegGuides | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png\",\"datePublished\":\"2022-10-11T09:17:56+00:00\",\"dateModified\":\"2024-11-21T21:27:00+00:00\",\"description\":\"Learn how RegASK assists CROs in fulfilling the regulatory requirements for implementing Decentralized Clinical Trials across countries.\u00a0\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/decentralized-clinical-trials-cros\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png\",\"width\":330,\"height\":300,\"caption\":\"Decentralized Clinical Trials How Cros Can Benefit From RegASK Solutions\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dezentrale CT: CROs profitieren von RegGuides | RegASK","description":"Erfahren Sie, wie RegASK CROs dabei unterst\u00fctzt, die gesetzlichen Anforderungen f\u00fcr die l\u00e4nder\u00fcbergreifende Durchf\u00fchrung dezentraler klinischer Studien zu erf\u00fcllen.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/dezentrale-klinische-studien-cros\/","og_locale":"de_DE","og_type":"article","og_title":"Decentralized Clinical Trials: How CROs can benefit from our RegGuides","og_description":"Learn how RegASK assists CROs in fulfilling the regulatory requirements for implementing Decentralized Clinical Trials across countries.\u00a0","og_url":"https:\/\/regask.com\/de\/dezentrale-klinische-studien-cros\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2022-10-11T09:17:56+00:00","article_modified_time":"2024-11-21T21:27:00+00:00","og_image":[{"width":330,"height":300,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/#article","isPartOf":{"@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Decentralized Clinical Trials: How CROs can benefit fro&hellip;","datePublished":"2022-10-11T09:17:56+00:00","dateModified":"2024-11-21T21:27:00+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/"},"wordCount":243,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png","articleSection":["Case Studies","Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/","url":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/","name":"Dezentrale CT: CROs profitieren von RegGuides | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png","datePublished":"2022-10-11T09:17:56+00:00","dateModified":"2024-11-21T21:27:00+00:00","description":"Erfahren Sie, wie RegASK CROs dabei unterst\u00fctzt, die gesetzlichen Anforderungen f\u00fcr die l\u00e4nder\u00fcbergreifende Durchf\u00fchrung dezentraler klinischer Studien zu erf\u00fcllen.\u00a0","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/decentralized-clinical-trials-cros\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/decentralized-clinical-trials-cros\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png","width":330,"height":300,"caption":"Decentralized Clinical Trials How Cros Can Benefit From RegASK Solutions"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/3883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=3883"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/3883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/3954"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=3883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=3883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=3883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}